Loading…
Loading…
KMED (KraneShares Emerging Markets Healthcare Index ETF) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
See exactly how KMED's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for KMED and 80,000+ other tickers.
This fund aims to invest a minimum of 80% of its total assets in holdings that are either directly part of its reference index or possess comparable economic characteristics. The benchmark index itself is composed of companies, classified by RBICS, operating in various healthcare sectors, including pharmaceutical development, biotechnology, specialized medical products, managed healthcare services, hospital and nursing home administration, direct medical and nursing care, and other support services for the health industry. It's important to note that this fund is not diversified.
The first week of October saw a flood of new ETFs, with 28 funds debuting on U.S. exchanges. Part of that was due to the first Ethereum futures ETFs being approved to launch on Monday.
The Chinese government has promised 2 billion vaccines to help developing nations in the face of the highly contagious Covid-19 variant delta, as reported by the Wall Street Journal. President XI Jinping pledged the vaccines Thursday, while also calling for greater international cooperation in vaccine export and distribution.
Emerging markets (EM) took their lumps from the Covid-19 pandemic, but as these economies re-emerge, look to strength in the healthcare sector with the KraneShares Emerging Markets Healthcare Index ETF (KMED). An increase in healthcare spending could boost the sector as the overall global population starts to age.
On Tuesday, the World Health Organization approved a Covid-19 vaccine produced by Sinovac Biotech for emergency use, the second vaccine created in China to be approved according to Reuters. That could be good news for the KraneShares Emerging Market Healthcare Index ETF (NYSE: KMED), which holds several Chinese pharmaceutical stocks.
One of the asset classes generating plenty of buzz as a 2021 idea is emerging markets. Up 4.5% over the past month, the MSCI Emerging Markets Index is already pricing in that enthusiasm.